Arcutis Biotherapeutics, Inc. ARQT Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s common stock, shares issued (in shares)?
- Arcutis Biotherapeutics, Inc. (ARQT) reported common stock, shares issued (in shares) of $125.04M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s common stock, shares issued (in shares) changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s common stock, shares issued (in shares) increased by 5.0% year-over-year, from $119.14M to $125.04M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s common stock, shares issued (in shares)?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s common stock, shares issued (in shares) has grown at a 23.1% compound annual growth rate (CAGR), from $43.68M to $123.33M.